Virus-induced senescence: A therapeutic target to mitigate severe progression of SARS-COV-2

Expert Opin Ther Targets. 2023 Apr-May;27(4-5):263-267. doi: 10.1080/14728222.2023.2218033. Epub 2023 May 27.

Authors

Mani Iyer Prasanth^{1

2}, James Michael Brimson^{1

3}, Tewin Tencomnao^{1

2}

Affiliations

¹ Natural Products for Neuroprotection and Anti-Ageing Research Unit, Chulalongkorn University, Bangkok, Thailand.
² Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
³ Innovation and International Affairs, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.

PMID: 37222592
DOI: 10.1080/14728222.2023.2218033

No abstract available

Keywords: COVID-19; COVID-19 therapeutics; SARS-CoV-2; global pandemic; senolytic drugs.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / pharmacology
COVID-19*
Humans
SARS-CoV-2*

Substances

Antiviral Agents